Correlation Between Neurocrine Biosciences and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Neurocrine Biosciences and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Takeda Pharmaceutical.

Diversification Opportunities for Neurocrine Biosciences and Takeda Pharmaceutical

-0.56

Correlation Coefficient

Neurocrine Biosciences  Takeda Pharmaceutical

Excellent diversification

The 3 months correlation between Neurocrine and Takeda is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Takeda Pharmaceutical

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 1.67 times more return on investment than Takeda Pharmaceutical. However, Neurocrine Biosciences is 1.67 times more volatile than Takeda Pharmaceutical Co. It trades about 0.07 of its potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about -0.11 per unit of risk. If you would invest  12,128  in Neurocrine Biosciences on September 12, 2024 and sell it today you would earn a total of  768.00  from holding Neurocrine Biosciences or generate 6.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Neurocrine Biosciences  vs.  Takeda Pharmaceutical Co

Neurocrine Biosciences

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting forward indicators, Neurocrine Biosciences may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with Neurocrine Biosciences and Takeda Pharmaceutical

The main advantage of trading using opposite Neurocrine Biosciences and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind Neurocrine Biosciences and Takeda Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.